US Pharma MarketingLilly signals move into aesthetics, looking to add products for body, skin and hair
Eli Lilly posts a job to scout aesthetics deals in skin, hair and body shape, despite past pushback on cosmetic use of its obesity drugs. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene…
Eli Lilly is looking to get into the aesthetics business and acquire drugs that could treat skin aging and diseases, body shape and hair conditions, according to a new job posting.
The
Source: Endpoints News